Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.

"Transparency declarations: P.R. is a staff member of the World Health Organization. The authors alone are responsible for the views expressed in this publication that do not necessarily represent the decisions, policy or views of the World Health Organization. There are no other conflicts of interest to report. None of the authors declared financial conflict of interest.: Author contributionsData acquisition: M.M.K., C.R., S.S., A.B., N.K., S.K., C.K., N.K., R.E., C.K., C.K., S.C. Data analyses: M.M.K., C.R., N.K., R.L., P.R., J.C.B., B.W. Sampling and data management: S.K. Study design: J.C.B., B.W. Funding acquisition: J.C.B., B.W. Manuscript redaction: M.M.K., C.R., P.R., J.C.B. and B.W."

"Funding This study was funded by the Bill & Melinda Gates Foundation and Global Fund/UNOPS through WHO and by the Institut Pasteur Department of International Affairs. M.M.K. was supported by the 5% initiative (MIVS-ACT, grant #15SANIN211)."